April 20, 2012
On April 19, 2012, Lantheus issued a customer letter to provide an update on the previous communication regarding the possible supply shortage of Xenon-133. After detailed discussions with suppliers, Lanthius expects to receive supply for one more week. The supply shortage of Xenon-133 is estimated to be from May 16 to May 29 and is anticipated to be restored to normal supply by May 30.
Xenon-133 is a critically important diagnostic tool that is instrumental in the timely and accurate diagnosis of a number of pulmonary conditions, including pulmonary embolism, a condition that is potentially fatal for patients. The use of Xenon-133 is highly used by clinicians during emergency procedures in order to prevent potentially fatal conditions, including those involving problems with cerebral blood flow.
The SNM will keep you updated on any changes that may occur. To view the customer letter, please click on the attached document.